Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Peter Marks’ Fears May Come True: White House Wants More In-Person Work

Executive Summary

The CBER director has worried that ‘someone’ might try to end the US FDA’s hybrid work policy. Now the push against it is bipartisan.

You may also be interested in...



Janet Woodcock Retires From US FDA: ‘I’m Trying To Tie Up All The Loose Ends’

On the eve of departure after more than 37 years of service to FDA, the agency’s principal deputy commissioner discusses her legacy, issues that others will take up, and preparing the agency for change in a Pink Sheet interview.

Janet Woodcock Retires From US FDA: ‘I’m Trying To Tie Up All The Loose Ends’

On the eve of departure after more than 37 years of service to FDA, the agency’s principal deputy commissioner discusses her legacy, issues that others will take up, and preparing the agency for change in a Pink Sheet interview.

Califf Hires New US FDA Senior Advisor, But Duties Seem Vague

As a senior advisor for chronic disease, Haider Warraich will help shape policy and product development in several areas, but the FDA provided few details on the cardiologist’s new duties.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS148674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel